Current Issue: Transcriptomic Features of Cribriform and Intraductal Carcinoma of the Prostate buff.ly/3hAVkSX @lone_zaeem Tarik Benidir Monica Nair Elai Davicioni Ewan Gibb Sean R Williamson MD Shilpa Gupta Rahul Tendulkar, MD Chris Weight Jane K Nguyen MD PhD Eric Klein Omar Mian

Risk assessment in localized #ProstateCancer - Insights from real-world data and SEER registry. Jim Hu Weill Cornell Medicine joins Ashley Ross MD PhD NM Urology to discuss the use of genomic classifiers in the mgmt of localized PCa on UroToday > bit.ly/3VSVvJc Decipher by Veracyte

Cross-Comparison IPD Analysis of Three Gene Expression Signatures in Localized #prostatecancer in >50,000 Men #ASTRO23 Angela Jia UroToday.com 📌 15,379 NCCN low-risk, 14,773 fav int-risk, 15,544 unfav int-risk, and 5,185 high/very high-risk 📌 Oncotype model had poor

New #JITC article: Analysing the tumor transcriptome of prostate cancer to predict efficacy of Lu-PSMA therapy bit.ly/3rPdfuA

Thanks Sophia Kamran, MD David Miyamoto MD PhD Jason for continued collaboration

We will be attending the Society of Urologic Oncology meeting it will be taking place on November 28th - December 1st 2023 in Washington, DC! Visit our booth & learn how Veracyte, Inc.'s Decipher Prostate GC can help men living with #ProstateCancer

Open for inclusion: Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (THUNDER): A Two-part Phase 2/ 3 Trial.

Awesome study led by Udit Singhal, MD and Robert Dess combining STAR-CAP prognostic score with genomic risk using Decipher by Veracyte GRID as well as MUSIC Urology data. Gives a cool picture of how clinical and genomic risk differ and can be additive. #AUA24

Our latest paper on ctDNA detection using WGS is now published in European Urology. This WGS-based approach simplifies clinical workflows by eliminating the need for personalized assays. Read the paper here : doi.org/10.1016/j.euru…

Articles in Press: Whole-genome Mutational Analysis for Tumor-informed Detection of Circulating Tumor DNA in Patients with Urothelial Carcinoma by Iver Nordentoft and Sia Viborg Lindskrog et al Read the full article here: europeanurology.com/article/S0302-… #UroSoMe #Medtwitter #BladderCa

Excited to share our manuscript addressing a novel linkage between the Decipher genomic classifier and real-world clinical data with >92,000 patients securely linked jamanetwork.com/journals/jaman… Chris Filson Tyler Seibert MD PhD Decipher by Veracyte Elai Davicioni Matt Cooperberg

Grateful to collaborate with Chris Filson Elai Davicioni Tyler Seibert MD PhD Daniel E Spratt Matt Cooperberg @ ashley ross @ preston sprenkle Yale Urology Decipher by Veracyte

1/3 Nice work Alec Zhu Elai Davicioni Ashley Ross MD PhD Daniel E Spratt Edward Schaeffer, MD, PhD on Decipher use and outcomes in SEER.

3/3 Use of Decipher Prostate Biopsy Test in Patients with Favorable-risk D... sciencedirect.com/science/articl…

Great work by John Nikitas . and Jeremie Calais Johannes Czernin Robert Reiter Himanshu Nagar Elai Davicioni Adam B. Weiner, MD out now in JCO Precision Oncology . Decipher highly correlated with upstaging by PSMA PET both pre-treatment and post-RP in this multi-institutional study.

A new study in JCO Precision Oncology shows that Decipher Prostate results align with cancer spread found on PSMA PET in #ProstateCancer patients pre- and post-treatment. Results suggest Decipher testing could help determine which patients need a PSMA PET scan.

Huge congrats to Cathy Handy Marshall, MD MPH and Benjamin Teply for this paradigm-breaking study. In BCR prostate cancer, Olaparib shows profound activity (w/out ADT!) in HRRm+ pts, esp. in BRCA2+ pts (100% response rate). The PCCTC Johns Hopkins Kimmel Cancer Center @umncancer jamanetwork.com/journals/jamao…